Fig. 4From: Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatinKaplan–Meier curves of overall survival according to groups based on the results of multivariable analysis and log-rank test. a Classified by NLR ≥3. b Classified by CA19–9 ≥ 500 U/mL and CEA ≥ 5 ng/mL. NLR, neutrophil-to-lymphocyte ratio; CA 19–9, carbohydrate antigen 19–9; CEA, carcinoembryonic antigenBack to article page